Concepedia

Emad Abro

EA

Statistics

Publications

8

Citations

270

H-Index

8

Active since

2013

Affiliations

Princess Alexandra Hospital(Current)

Peter MacCallum Cancer Centre

The University of Queensland

The Royal Melbourne Hospital

South Australian Health and Medical Research Institute

Emad Abro is an author at Princess Alexandra Hospital specializing in medicine, oncology, and chemotherapy.

ORCID

Publications per year

2013–2024

8

Publications

8

LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma

Colm Keane, Soi Cheng Law, Clare Gould et al. · Blood Advances · 2020 · 96 citations · Full text

, , +17

Clinical impact of <i>NPM1</i>-mutant molecular persistence after chemotherapy for acute myeloid leukemia

Ing Soo Tiong, Richard Dillon, Adam Ivey et al. · Blood Advances · 2021 · 40 citations · Full text

, , +15

Gemcitabine‐induced thrombotic microangiopathy

Joshua Richmond, Peter J Gilbar, Emad Abro · Internal Medicine Journal · 2013 · 30 citations

, , +9

Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC)

Ing Soo Tiong, Devendra Hiwase, Emad Abro et al. · Journal of Clinical Oncology · 2024 · 28 citations · Full text

, , +15

Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance

Joshua W.D. Tobin, Gabrielle Rule, Katherine Colvin et al. · Blood Advances · 2019 · 26 citations · Full text

, , +15

1–5 of 8